Screening visit and informed consent | |
- Informational session about study requirements | |
- Obtain informed consent | |
- Verify inclusion criteria (i.e., BMI and blood pressure) | |
- Physical exam/review of medications | |
- Non-exercise physical activity via activPAL | |
- Exercise calendar and Barriers screening forms | |
- Complete metabolic panel, lipids, insulin, C-reactive protein, and blood chemistries | |
Baseline | |
- PWV, muscle biopsy, IVGTT, and NIRS | |
- SF-36 and FFQ | |
- Body weight, blood pressure, anthropometry, DEXA, and maximal exercise test | |
Randomization | |
- CON, MOD-INT, or HIGH-INT group | |
Mid-intervention (12 weeks) | |
- Waist circumference | |
- Body weight | |
- Maximal exercise test | |
Follow-up (24 weeks) | |
- Non-exercise physical activity via activPAL | |
- PWV, muscle biopsy, IVGTT, and NIRS | |
- SF-36 and FFQ | |
- Complete metabolic panel, lipids, insulin, C-reactive protein, and blood chemistries | |
- Body weight, blood pressure, anthropometry, DEXA, and maximal exercise test |